DealRetro Biosciences, a Redwood City, CA-based longevity startup, is reportedly raising $1 billion in a Series A round backed by Sam Altman. The funding is said to value the company at $5 billion, though final details remain unconfirmed.
More on STAT+ →
SERIES A
12/05/2025
NanoZymeX, a Basel, Switzerland-based nanobiotech enzyme therapy platform,...
Flourish Care, a Boston-based women’s mental health platform, raised...
Cellbricks Therapeutics, a Berlin, Germany-based biofabricated tissue...
Bioniq, a London-based personalised health platform, was acquired for $150...
Terns Pharmaceuticals, Inc., a Foster City, CA-based leukemia therapy...
Ouro Medicines, a Cambridge, MA-based clinical-stage immunology biotech,...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.
